These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 23303849)

  • 1. Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.
    Leung KK; Bartlett JW; Barnes J; Manning EN; Ourselin S; Fox NC;
    Neurology; 2013 Feb; 80(7):648-54. PubMed ID: 23303849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia.
    Bartel F; Visser M; de Ruiter M; Belderbos J; Barkhof F; Vrenken H; de Munck JC; van Herk M;
    Neuroimage Clin; 2019; 23():101902. PubMed ID: 31233953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting.
    Tang X; Holland D; Dale AM; Younes L; Miller MI;
    Hum Brain Mapp; 2014 Aug; 35(8):3701-25. PubMed ID: 24443091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study.
    Liu G; Liu C; Qiu A;
    Hum Brain Mapp; 2021 Jun; 42(9):2931-2940. PubMed ID: 33739550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.
    Falahati F; Ferreira D; Muehlboeck JS; Eriksdotter M; Simmons A; Wahlund LO; Westman E
    Neuroimage Clin; 2017; 16():418-428. PubMed ID: 28879083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer's disease.
    Babiloni C; Carducci F; Lizio R; Vecchio F; Baglieri A; Bernardini S; Cavedo E; Bozzao A; Buttinelli C; Esposito F; Giubilei F; Guizzaro A; Marino S; Montella P; Quattrocchi CC; Redolfi A; Soricelli A; Tedeschi G; Ferri R; Rossi-Fedele G; Ursini F; Scrascia F; Vernieri F; Pedersen TJ; Hardemark HG; Rossini PM; Frisoni GB
    Hum Brain Mapp; 2013 Jun; 34(6):1427-46. PubMed ID: 22331654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.
    Henneman WJ; Sluimer JD; Barnes J; van der Flier WM; Sluimer IC; Fox NC; Scheltens P; Vrenken H; Barkhof F
    Neurology; 2009 Mar; 72(11):999-1007. PubMed ID: 19289740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.
    Nestor SM; Rupsingh R; Borrie M; Smith M; Accomazzi V; Wells JL; Fogarty J; Bartha R;
    Brain; 2008 Sep; 131(Pt 9):2443-54. PubMed ID: 18669512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year Follow-up Study of Hippocampal Subfield Atrophy in Alzheimer's Disease and Normal Aging.
    Madusanka N; Choi HK; So JH; Choi BK; Park HG
    Curr Med Imaging Rev; 2019; 15(7):699-709. PubMed ID: 32008518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.
    Jack CR; Petersen RC; Xu Y; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Tangalos EG; Kokmen E
    Neurology; 2000 Aug; 55(4):484-89. PubMed ID: 10953178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Accelerated and Non-accelerated MRI Scans for Brain Volume and Boundary Shift Integral Measures of Volume Change: Evidence from the ADNI Dataset.
    Manning EN; Leung KK; Nicholas JM; Malone IB; Cardoso MJ; Schott JM; Fox NC; Barnes J;
    Neuroinformatics; 2017 Apr; 15(2):215-226. PubMed ID: 28316055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrophy rates accelerate in amnestic mild cognitive impairment.
    Jack CR; Weigand SD; Shiung MM; Przybelski SA; O'Brien PC; Gunter JL; Knopman DS; Boeve BF; Smith GE; Petersen RC
    Neurology; 2008 May; 70(19 Pt 2):1740-52. PubMed ID: 18032747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.
    Manning EN; Barnes J; Cash DM; Bartlett JW; Leung KK; Ourselin S; Fox NC;
    PLoS One; 2014; 9(5):e97608. PubMed ID: 24878738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
    Jack CR; Shiung MM; Gunter JL; O'Brien PC; Weigand SD; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Cha RH; Tangalos EG; Petersen RC
    Neurology; 2004 Feb; 62(4):591-600. PubMed ID: 14981176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
    Morra JH; Tu Z; Apostolova LG; Green AE; Avedissian C; Madsen SK; Parikshak N; Hua X; Toga AW; Jack CR; Schuff N; Weiner MW; Thompson PM;
    Hum Brain Mapp; 2009 Sep; 30(9):2766-88. PubMed ID: 19172649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations.
    Evans MC; Barnes J; Nielsen C; Kim LG; Clegg SL; Blair M; Leung KK; Douiri A; Boyes RG; Ourselin S; Fox NC;
    Eur Radiol; 2010 Mar; 20(3):674-82. PubMed ID: 19760240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cerebellum shrinks faster than normal ageing in Alzheimer's disease but not in mild cognitive impairment.
    Tabatabaei-Jafari H; Walsh E; Shaw ME; Cherbuin N;
    Hum Brain Mapp; 2017 Jun; 38(6):3141-3150. PubMed ID: 28321950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.
    Jack CR; Shiung MM; Weigand SD; O'Brien PC; Gunter JL; Boeve BF; Knopman DS; Smith GE; Ivnik RJ; Tangalos EG; Petersen RC
    Neurology; 2005 Oct; 65(8):1227-31. PubMed ID: 16247049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of hippocampal and temporal horn volumes and rates of change in predicting future conversion to AD.
    Macdonald KE; Bartlett JW; Leung KK; Ourselin S; Barnes J;
    Alzheimer Dis Assoc Disord; 2013; 27(2):168-73. PubMed ID: 22760170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional signature of conversion of patients with mild cognitive impairment.
    Delli Pizzi S; Punzi M; Sensi SL;
    Neurobiol Aging; 2019 Feb; 74():21-37. PubMed ID: 30408719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.